Zdrowie i gospodarka · 24/01/2023
FDA Releases Final Guidance on Cannabis Quality Considerations for Clinical Research
The US Food and Drug Administration (FDA) has released a final guidance document outlining quality considerations for clinical research involving cannabis and cannabis-derived compounds, aiming to support the development of human drugs containing these substances.